Shareholder structure

DSM-Firmenich AG and Group companies

DSM-Firmenich AG is the parent company of the dsm-firmenich Group (the ‘Group’ or ‘dsm-firmenich’, with dual headquarters in Maastricht and Kaiseraugst). DSM-Firmenich AG is a Company organized under Swiss law with its registered office at Wurmisweg 576, 4303 Kaiseraugst, Switzerland. The Group’s operating businesses are organized into three Business Units: Perfumery & Beauty, Taste, Texture & Health and Health, Nutrition & Care. The principal subsidiaries of the Group are shown in Investments - dsm-firmenich Integrated Annual Report 2025.

Share Capital

On February 26, 2026, the total number of issued shares was reduced to 253,626,947 shares. The capital amounts to €2.5 million (CHF 2.3 million), with one class of shares. All DSM-Firmenich AG shares have a nominal value of €0.01 each, with one share carrying one vote. The outstanding shares provide an entitlement of one vote per share at the Annual General Meeting.

It is mandatory for shareholders with a holding of 3% or more in the Company to make the relevant disclosures to the Dutch Authority for the Financial Markets (AFM) and the SIX Exchange Regulation (SER). Further information about registered shareholders of the Company can be found here.

Shareholder sell-down arrangements

In connection with the dual listing of the Company on both Euronext Amsterdam and SIX Swiss Exchange, the parties to the Business Combination Agreement dated May 30, 2022, have agreed that the orderly marketing (sell-down) restrictions applicable to the Firmenich shareholders will cease to apply with effect from May 21, 2026, the date of the dual listing in Switzerland.

Contact Investor Relations

Whether you’re a shareholder, potential shareholder, or analyst, our Investor relations team is on hand to answer your questions.

Explore more
  • Share performance

    Tools to track your share performance.

  • Dividends

    All the key details about dsm-firmenich’s dividend policy.

  • Shares & ADRs

    All the key details on holding and trading shares of dsm-firmenich.

Stay up to date

Be the first to know about key news as we continue shaping the future and bringing progress to life.